Evidence map›Paper›PMID 34938747›Full record

ArticleFrontiers in medicine2021

CD200R Combined Neutrophil-Lymphocyte Ratio Predict 90-Day Mortality in HBV-Related Acute-On-Chronic Liver Failure.

Yuxin Li, Yaxian Kong, Ke Shi, Yunyi Huang, Qun Zhang, Bingbing Zhu, Hui Zeng, Xianbo Wang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Expression of CD38Scientific reports · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuxin LiCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yaxian KongBeijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Ke ShiCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Yunyi HuangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Qun ZhangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Bingbing ZhuCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Hui ZengBiomedical Innovation Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Xianbo WangCenter of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Capital Medical University · CNBeijing Ditan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ACLFCD200RHBVNLRprognosisT cell

Identifiers

PMID34938747
PMCPMC8685236
OpenAlexW4200151426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.